SUBSYS Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8835459 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(2 years from now) | |
| US9289387 | BTCP PHARMA | Method of treating pain by administering sublingual fentanyl spray |
Jan, 2027
(2 years from now) | |
| US10610523 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(2 years from now) | |
| US10016403 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(2 years from now) | |
| US9642844 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(2 years from now) | |
| US8835460 | BTCP PHARMA | Sublingual fentanyl spray and methods of treating pain |
Jan, 2027
(2 years from now) | |
| US9241935 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(2 years from now) | |
| US9642797 | BTCP PHARMA | Sublingual fentanyl spray and methods of use to treat pain |
Jan, 2027
(2 years from now) | |
| US8486973 | BTCP PHARMA | Sublingual fentanyl spray |
Apr, 2030
(6 years from now) | |
| US8486972 | BTCP PHARMA | Sublingual fentanyl spray |
Apr, 2030
(6 years from now) | |
Subsys is owned by Btcp Pharma.
Subsys contains Fentanyl.
Subsys has a total of 10 drug patents out of which 0 drug patents have expired.
Subsys was authorised for market use on 04 January, 2012.
Subsys is available in spray;sublingual dosage forms.
Subsys can be used as treatment of pain.
The generics of Subsys are possible to be released after 27 April, 2030.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Jan 04, 2015 |
Drugs and Companies using FENTANYL ingredient
Market Authorisation Date: 04 January, 2012
Treatment: Treatment of pain
Dosage: SPRAY;SUBLINGUAL
How can I launch a generic of SUBSYS before it's drug patent expiration?
More Information on Dosage
SUBSYS family patents
